In vivo, in mouse models, confirms that block IGF-I signalling demonstrate efficacy in inducing tumour regression and growth arrest [29] and sensitized cancer cells to conventional chemotherapeutic treatment and irradiation [67]. This evidence concerns the gene IGF1 and cancer.